Telemedicine for neonatal resuscitation? @jenfang0908 shares the opportunities #HotTopicsNeo2020 #neoEBM
Can technology and telemedicine help close the gap in the mortality disparity for inborn and outborn infants?
Dr. Fang conducted a simulated study where pediatric trainees were assigned to two groups, one with telemedicine support
This simulation study reduced the time to effective ventilation and supported the rationale for a pilot development of a telemedicine program at @MayoClinic that now serves 19 community hospitals, covering 17,000 deliveries per year
Snapshots of a telemedicine consult - opportunities to interact with the bedside team in the delivery room and guide resuscitation by a remote neonatologist
Telemedicine may help to address inequality by increasing access to a neonatologist to all newborns
Dr. Fang also highlights the potential for telemedicine to reduce medicolegal liability based on the experience at @MayoClinic
Does telemedicine improve outcomes of newborn resuscitation?

Here is the study by @jenfang0908 et al: pubmed.ncbi.nlm.nih.gov/29408329/
Data suggested that telemedicine improved the quality of neonatal resuscitation, with associated increases in measurement of temperature, blood glucose, and blood gas
Potential opportunities for telemedicine regarding access, patient safety and quality of neonatal resuscitation #neoEBM #HotTopicsNeo2020

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Evidence-Based Neo

Evidence-Based Neo Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @EBNEO

7 Dec
To conclude "New Approaches to Cooling", Sudhin Thayyil (@SudhinThayyil) of @imperialcollege discusses the “Hypothermia for Encephalopathy in Low and Middle-Income Countries (HELIX) Trial”

Trial protocol: pubmed.ncbi.nlm.nih.gov/28923118/

#HotTopicsNeo2020 @HotTopicsNeo #neoebm Image
Thayyil: current guidelines recommend therapeutic cooling in LMIC settings. Supported by MA findings, but based on small, low quality studies.

#HotTopicsNeo2020 @HotTopicsNeo #neoebm ImageImage
Thayyil: Aim, setting, eligibility, sample size and target outcomes for the HELIX trial.

#HotTopicsNeo2020 @HotTopicsNeo #neoebm ImageImageImageImage
Read 8 tweets
7 Dec
Next up in "New Approaches to Cooling" Deirdre Murray of @CUH_Cork discussing “Neurodevelopmental Outcomes after Mild HIE.” Read more about Prof. Murray and her work: infantcentre.ie/who-we-are-2/o…

#HotTopicsNeo2020 @HotTopicsNeo Image
Murray begins by defining the population discussed in her lecture: those with encephalopathy 2/2 perinatal asphyxia.

#HotTopicsNeo2020 @HotTopicsNeo Image
How do infants with different HIE severity grades perform on IQ testing at 5 years of age? Summary from:
pubmed.ncbi.nlm.nih.gov/27650049/, which includes additional outcomes measures.

Take home point: mild and moderate HIE infants similar.

#HotTopicsNeo2020 @HotTopicsNeo Image
Read 6 tweets
7 Dec
Last in the Rx for BPD trio at #HotTopicsNeo2020: Dr. Reese Clark of @MEDNAX with: "What Drugs are we Using? Practice Variability and Potential Harm." Read more about Dr. Clark's distinguished care:
blog.mednax.com/mednax-neonato…
@HotTopicsNeo Image
Reese: Talk to focus on steroid use. To begin, what postnatal steroids are we using? Dexamethasone and hydrocortisone most common systematic exposures, budenoside most common inhaled exposure.

#HotTopicsNeo2020 @HotTopicsNeo Image
The unstoppable pendulum of postnatal steroid use; data from @MEDNAX clinical data warehouse suggests use again on the rise.

#HotTopicsNeo2020 @HotTopicsNeo Image
Read 4 tweets
7 Dec
Next up in #HotTopicsNeo2020: Erik Jensen of @ChildrensPhila discussing how the baseline risk of BPD impacts the number needed to treat when considering effective therapies.

chop.edu/doctors/jensen…

@HotTopicsNeo Image
Presentation builds on recently published report in @JPediatr: drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat
jpeds.com/article/S0022-…

#HotTopicsNeo2020
Jensen: objectives of talk:

#HotTopicsNeo2020 @HotTopicsNeo Image
Read 8 tweets
7 Dec
From the last session on periviability at @HotTopicsNeo, let’s get the pulse of the #neoEBM community with a few surveys (thread) #HotTopicsNeo2020
What is the earliest gestational age, assuming dating is correct, where you (or your hospital) routinely offer active postnatal resuscitation if desired by the family
If an infant at 22-24 weeks GA has evidence of inadequate organ perfusion (low urine output, decreasing BP), what is your first line treatment:
Read 6 tweets
7 Dec
First up in: "Pharmacotherapy for BPD: We Know Less than We Think We Do" at #HotTopicsNeo2020 is Dr. Gerri Baer (@thegerribaer), Team Leader for Neonatology @US_FDA, discussing "Challenges in Studying Drugs for BPD"
@HotTopicsNeo #neoEBM Image
Baer: no (zero, zilch, none!) drugs approved in the USA to prevent or treat BPD.

Highlights various cohorts demonstrating the ongoing high burden of BPD:

#HotTopicsNeo2020 @HotTopicsNeo Image
Baer: broad view of challenges to BPD Rx, illustrated by 3 buckets: understanding phenotypes/endotypes, definitions and classification and choosing adequate endpoints.
#HotTopicsNeo2020 @HotTopicsNeo Image
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!